|
Research news about olanzapine (03/09/01s)
A number of articles about the antipsychotic substance olanzapine,
commersially known as Zyprexa, were recently published. Below is
a list of links to PubMed abstracts for these. All abstracts are
from The
Journal of Clinical Psychiatry 2001 Vol 62 Suppl 2.
Superior
efficacy of olanzapine over haloperidol: analysis of patients with
schizophrenia from a multicenter international trial.
Effective
resolution with olanzapine of acute presentation of behavioral agitation
and positive psychotic symptoms in schizophrenia.
The
efficacy of a rapid-acting intramuscular formulation of olanzapine
for positive symptoms.
An
efficacy analysis of olanzapine treatment data in schizophrenia
patients with catatonic signs and symptoms.
An
efficacy analysis of olanzapine treatment data in schizophrenia
patients with catatonic signs and symptoms.
Evidence
for the effectiveness of olanzapine among patients nonresponsive
and/or intolerant to risperidone.
Cardiac
safety parameters of olanzapine: comparison with other atypical
and typical antipsychotics.
Pharmacoeconomics also published an article in December 2000, about
olanzapine treatment seen from a clinical and economical perspective:
Olanzapine
versus risperidone. A prospective comparison of clinical and economic
outcomes in schizophrenia.
|
